Narayana Hrudayalaya
Market cap ₹38,412 Cr
- P/E
- 44.46
- Day range
- ₹1,869.30 – ₹1,918.80
- 52-week range
- ₹1,589.00 – ₹2,092.90
- Volume
- 77,210
- Open
- ₹1,898.10
- Prev close
- ₹1,907.60
Latest results · Q2 FY27(consolidated)Revenue ₹2,844 Cr+73.0%Profit ₹301 Cr+16.5%Margin 10.6%YoY vs the same quarter last year
No red flags in exchange filings: no rising pledge, promoter selling, surveillance or critical filing on record.
NH in NSE indices and F&O
Research profile
Composite 56 / 100Factor percentiles
Derived metrics
- Earn. yield
- 2.2%
- Graham no.
- ₹493.55
- vs Graham
- -73.9%
- ROE ÷ P/B
- 2.6%
- 12-1 mom.
- -5.1%
- Return / vol
- 0.15
- Magic Formula
- #432
- Piotroski
- 3/6
- FCF yield
- 1.9%
- PEG
- 2.69
Appears in 9 scans
Percentiles rank this stock against the other tracked stocks and change as they do. Scans describe where figures sit today. Hover a label for its definition. Not investment advice.
Peer comparison
All 68 in Pharma| Company | M-cap | P/E | P/B | ROE | ROCE | OPM | D/E | Sales YoY |
|---|---|---|---|---|---|---|---|---|
| Sun PharmaSUNPHARMA | ₹4.49 L Cr | 40.95 | 5.03 | 14.8% | 21.0% | 29.0% | 0.04 | +11.9% |
| Divi's LaboratoriesDIVISLAB | ₹2.93 L Cr | 87.19 | 16.88 | 16.2% | 22.0% | 43.0% | 0.00 | +35.4% |
| Torrent PharmaTORNTPHARM | ₹1.75 L Cr | 77.88 | 9.67 | 26.8% | 15.0% | 33.0% | 0.77 | +50.8% |
| Apollo HospitalsAPOLLOHOSP | ₹1.27 L Cr | 56.40 | 11.55 | 22.6% | 17.0% | 16.0% | 0.77 | +23.0% |
| Laurus LabsLAURUSLABS | ₹1.25 L Cr | 93.72 | 19.82 | 18.2% | 18.0% | 34.0% | 0.43 | +33.5% |
| Zydus LifesciencesZYDUSLIFE | ₹1.20 L Cr | 28.72 | 4.32 | 20.1% | 21.0% | 24.0% | 0.50 | +29.2% |
| Dr. Reddy's LabsDRREDDY | ₹1.17 L Cr | 41.63 | 2.97 | 11.6% | 13.0% | 20.0% | 0.19 | -1.5% |
| Narayana HrudayalayaNH | ₹38,412 Cr | 44.46 | 7.73 | 19.7% | 16.0% | 19.0% | 1.21 | +73.0% |
| Sector median | ₹24,603 Cr | 43.68 | 5.46 | 15.1% | 17.0% | 24.0% | 0.17 | +22.7% |
Sector as classified in the tracked universe; medians use every tracked Pharma company, and P/E only profitable ones. Tinted figures beat the median.
Latest news
Updated 2h agoHeadlines about Narayana Hrudayalaya from the last two weeks in the financial press. Stories belong to their publishers; Rajat Finance does not endorse them.
Key metrics
- P/E (TTM)
- 42.8
- Price / Book
- 7.72
- ROE (FY26)
- 19.7%
- ROCE (latest year)
- 16%
- Dividend yield
- 0.24%
Moving averages (NSE)
- 20-day
- ₹1,810.3
- Price above
- 50-day
- ₹1,810.14
- Price above
- 200-day
- ₹1,838.81
- Price above
Charts & trends
From company filings. Amounts in ₹ crore.
Revenue, profit & margin - quarterly
₹ crore; a loss shows red. Operating margin below, same periods.
- Revenue
- Net profit
Operating margin
Who owns the company
% of equity by quarter, latest Sept 2026
- Promoter
- Public
- DII
- FII
- Others
Cash flows
Where cash came from and went, by fiscal year (₹ crore)
- Operating
- Investing
- Financing
- Free cash flow
Return on equity
Net profit over shareholders' equity, by fiscal year
Equity vs debt
Shareholders' equity against borrowings (₹ crore); the ratio below, same years.
- Equity
- Debt
Debt to equity
Dividends per share
₹ by fiscal year of the ex-date; the latest year runs to date.
Financial statements
| Line item | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,204 | 1,246 | 1,306 | 1,367 | 1,335 | 1,475 | 1,507 | 1,644 | 2,151 | 2,594 | 2,684 | 2,844 |
| Expenses | 925 | 955 | 1,004 | 1,058 | 1,027 | 1,118 | 1,171 | 1,243 | 1,786 | 2,086 | 2,216 | 2,293 |
| Operating Profit | 279 | 291 | 302 | 309 | 307 | 358 | 337 | 401 | 365 | 508 | 468 | 551 |
| OPM % | 23% | 23% | 23% | 23% | 23% | 24% | 22% | 24% | 17% | 20% | 17% | 19% |
| Other Income | 18 | 26 | 24 | 23 | 18 | 20 | 24 | 24 | -29 | 25 | 35 | 52 |
| Interest | 25 | 28 | 34 | 35 | 37 | 41 | 45 | 42 | 65 | 91 | 87 | 97 |
| Depreciation | 63 | 65 | 61 | 65 | 70 | 82 | 84 | 87 | 122 | 154 | 156 | 163 |
| Profit before tax | 209 | 225 | 231 | 232 | 219 | 254 | 232 | 296 | 149 | 288 | 260 | 343 |
| Tax % | 10% | 15% | 13% | 14% | 12% | 22% | 15% | 13% | 15% | 22% | 20% | 12% |
| Net Profit | 188 | 191 | 202 | 199 | 193 | 197 | 197 | 258 | 127 | 224 | 207 | 301 |
| EPS in Rs | ₹9.20 | ₹9.33 | ₹9.85 | ₹9.72 | ₹9.44 | ₹9.65 | ₹9.62 | ₹12.64 | ₹6.20 | ₹10.96 | ₹10.14 | ₹14.73 |
From company filings, updated 17 Nov 2026. Consolidated figures where the company reports them. Information only, not investment advice.
Working-capital cycle
-9 days since Mar 2021
+10 days since Mar 2021
+27 days since Mar 2021
-26 days since Mar 2021
+19 days since Mar 2021
Strengths, risks & growth
Narayana Hrudayalaya Ltd is engaged in providing economical healthcare services. It has a network of multispecialty and super specialty hospitals spread across multiple locations. [1]
Strengths
- Company is expected to give good quarter
- Company has a good return on equity (ROE) track record: 3 Years ROE 24.5%
Risks
- Stock is trading at 7.74 times its book value
Compounded Sales Growth
- 10 Years
- +17%
- 5 Years
- +25%
- 3 Years
- +20%
- TTM
- +72%
Compounded Profit Growth
- 10 Years
- +42%
- 5 Years
- +155%
- 3 Years
- +12%
- TTM
- +6%
Stock Price CAGR
- 10 Years
- +19%
- 5 Years
- +26%
- 3 Years
- +16%
- 1 Year
- -6%
Return on Equity
- 10 Years
- +20%
- 5 Years
- +26%
- 3 Years
- +25%
- Last Year
- +21%
Strengths and risks are a machine-generated checklist, not advice; growth is compounded annually over each period.
Shareholding pattern
| Holder | Dec 2025 | Mar 2026 | Jun 2026 | Sept 2026 | Change |
|---|---|---|---|---|---|
| Promoter | 63.27% | 63.27% | 63.27% | 63.27% | 0.00 pp |
| FII | 11.10% | 9.98% | 9.40% | 9.01% | -0.39 pp |
| DII | 7.91% | 9.14% | 9.05% | 10.68% | +1.63 pp |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00 pp |
| Public | 17.09% | 16.98% | 17.65% | 16.42% | -1.23 pp |
| Others | 0.62% | 0.62% | 0.62% | 0.62% | 0.00 pp |
Filed with NSE for Sept 2026: promoters 63.27%, public 36.11%
Analysts & fund holdings
Who holds the shares, quarter by quarter
Mutual funds 8.70% (+1.31 pp)- Promoters63.7%
- Foreign institutions9.1%
- Mutual funds8.7%
- Insurance1.0%
- Other domestic institutions1.0%
- Retail8.2%
- Others8.3%
| Fund | % of company | % of fund | 3-month change |
|---|---|---|---|
| Mirae Asset Large & Midcap Fund | 1.87% | 1.70% | -0.03 pp |
| Mirae Asset Midcap Fund | 1.08% | 2.12% | +0.19 pp |
| Parag Parikh Flexi Cap Fund | 0.89% | 0.23% | -0.04 pp |
| Mirae Asset ELSS Tax Saver Fund | 0.76% | 1.20% | +1.21 pp |
| Axis Small Cap Fund | 0.74% | 0.98% | -0.14 pp |
Scorecard
- Performance
- Avg
- Valuation
- High
- Growth
- Low
- Profitability
- High
- Entry point
- Good
- Red flags
- Low
Analyst coverage, holdings and scorecard from market data; not a recommendation by Rajat Finance.
Risk & trend
From 292 daily sessions to 18 Nov 2026.
Risk
- Volatility (1Y)
- 29.5%
- Downside volatility
- 24.6%
- Worst 5% of days
- 2.5%
- Average of that tail
- 3.2%
- Max drawdown (1Y)
- 21.4%
- Below its peak
- 9.1%
Against the market
- Beta vs Nifty 50
- 0.77
- Correlation
- 0.36
- Relative strength (3M)
- -0.4%
- ATR (14)
- 2.6%
Return
- Return 1M
- +10.0%
- Return 3M
- +3.4%
- Return 6M
- +1.3%
- Return 1Y
- +4.4%
- vs 200-day average
- +2.9%
Momentum
- RSI (14)
- 59.7
- MACD histogram
- 9.98
- Stochastic %K
- 77.4
- ADX (14)
- 27.9
- +DI / −DI
- 28.1 / 18.2
- Money flow index
- 78.3
Participation
- Delivery (20d avg)
- 51.9%
- vs its 60-day baseline
- -2.8 pts
- Volume vs 20-day
- -0.7σ
- Close vs day's VWAP
- +0.3%
- 52-week position
- 60 / 100
These describe what this stock's price has already done. They are not forecasts, signals or recommendations, and a dash means the figure was withheld for want of enough history rather than being zero.
Financial quality
From consolidated statements to 30 Sept 2026.
Piotroski F-Score
3 of 6 tested
- Return on assets positive — passed
- Operating cash flow positive — not testableno cash flow statement for this period
- Return on assets improving — failed
- Cash flow exceeds profit — not testableneeds cash flow and profit against assets
- Debt to assets falling — failed
- Current ratio improving — passed
- No new equity issued — not testableno share count is collected, and financing cash flow mixes equity with debt
- Operating margin improving — failed
- Asset turnover improving — passed
- Free cash flow
- ₹746 Cr
- FCF yield
- 1.9%
- Cash conversion
- 2.01
- Accruals ratio
- -0.065
- Net debt
- ₹5,578 Cr
- Net debt / equity
- 1.11
- EV / sales
- 4.28
- PEG
- 2.69
- Capex intensity
- 11.1%
- Revenue CAGR
- 54.8%
- Profit CAGR
- 32.5%
Computed from filed statements, not filed themselves. A dash means an input was absent, and the score counts only the criteria that could actually be tested.
Insider trades
| Person | Type | Shares | Value | Disclosed |
|---|---|---|---|---|
Shakuntala Shetty Promoters · Market Sale | Sell | 11,77,000 | ₹231 Cr | 27 Nov 2025 |
Disclosures filed with NSE under SEBI (Prohibition of Insider Trading) Regulations. Pledges and releases are not trades and are not counted above.
Corporate actions
- dividend₹4.50
Dividend - Rs 4.50 Per Share
17 Jul 2026ex-date - dividend₹4.50
Dividend - Rs 4.50 Per Share
1 Aug 2025ex-date - dividend₹4.00
Dividend - Rs 4 Per Share
2 Aug 2024ex-date - dividend₹2.50
Dividend - Rs 2.50 Per Share
7 Jul 2023ex-date - dividend₹1.00
Dividend - Rs 1 Per Share
22 Aug 2022ex-date - dividendNot available — not reported in this filing
Interim Dividend - Re 1 Per Share
11 Mar 2020ex-date - dividendNot available — not reported in this filing
Dividend - Re 1 Per Share
1 Aug 2019ex-date
Company announcements
Pursuant to Regulation 30 read with Para B of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed is the Intimation of commencement ....
Intimation about execution of operation and Management agreement Regaultino 30 read with Schedule III Part A Para B of the SEBI LODR Regualtions 2015
Submission of Scrutinizer report and Voting results of Postal Ballot conducted through remote e-voting
Intimation under Regulation 30 read with Para A of Part A of Schedule III of the SEBi LODR Regulations, 2015
Intimation for Closure of Trading Window for the quarter ended September 30, 2026.
Intimation of Change in Corporate Office Address of the Company.
Newspaper Advertisement of Postal Ballot Notice.
Notice of Postal Ballot
Schedule of meet of investors to be held on August 20, 2026
Voting results and scrutinizers report on the resolutions passed at 26th Annual General meeting held on August 14 2026
Summary of Proceedings of the 26th Annual General Meeting of the company held on Friday, August 14, 2026.
Transcript of the Earnings Call of the company for the quarter ended June 30, 2026.
Intimation of Schedule of Group Investor Meeting to be held on August 12, 2026.
Schedule of meet of investors to be held on August 07, 2026
Schedule of meet of investors to be held on August 06, 2026
Filed with BSE (scrip 539551); the last 45 days. Documents open at bseindia.com.
Documents
Annual reports
Earnings calls
- Nov 2026TranscriptSlidesRecording
- Oct 2026Slides
- Aug 2026TranscriptSlidesRecording
- Jul 2026Slides
- Jun 2026TranscriptSlidesRecording
- Feb 2026TranscriptSlidesRecording
Credit ratings
- Rating update · 24 Mar from icra
- Rating update · 19 Jan from icra
- Rating update · 10 Nov 2025 from icra
- Rating update · 20 Jan 2025 from icra
- Rating update · 2 Feb 2024 from icra
- Rating update · 6 Mar 2023 from icra
Documents open at BSE or the rating agency that issued them.
Sourced from the company's NSE XBRL filing dated 31 Oct 2026 (unaudited). View the source filing. Figures are as filed and are not investment advice.
Narayana Hrudayalaya: common questions
Answered from the figures on this page.